Cyclerion Therapeutics, Inc. (CYCN) Financials
CYCN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 15.2 million | 2.3 million |
2023-06-30 | 10.1 million | 4.9 million |
2023-03-31 | 11.5 million | 7.5 million |
2022-12-31 | 18.1 million | 7.6 million |
CYCN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.9 million | 159000 |
2023-06-30 | -6.6 million | 379000 |
2023-03-31 | -6.2 million | 426000 |
2022-12-31 | -7.0 million | 1.1 million |
CYCN Net Income
No data available :(
CYCN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 9.1 million | - | - |
2023-06-30 | 5.6 million | - | - |
2023-03-31 | 7.2 million | - | - |
2022-12-31 | 13.4 million | - | - |
CYCN Shares Outstanding
CYCN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 580000 | 2.1 million | - |
2023-06-30 | - | 886000 | 3.4 million | - |
2023-03-31 | - | 3.8 million | 3.3 million | - |
2022-12-31 | - | 4.5 million | 3.5 million | - |
CYCN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | 1.6 million | - |
CYCN
Price: $2.82
52 week price:
Earnings Per Share: -5.39 USD
P/E Ratio: -0.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 146600
Market Capitalization: 8.3 million